Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene-guided Warfarin in Acute Ischemic Stroke
NCT04482842Withdrawn
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of warfarin in ischemic stroke (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Stroke recurrence rate at 12 months and compliance rate of INR value at 12 months. Planned start Dec 2020; status: withdrawn.
02
Drugs
warfarin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04482842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04482842.